Cerevel Therapeutics Holdings Inc (CERE) Gross Profit Margin starting from the first quarter 2024 to first quarter 2023, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Cerevel Therapeutics Holdings Inc   (NASDAQ: CERE)


Cerevel Therapeutics Holdings Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



CERE Gross Profit Margin (Mar 31 2024)
Q1
(Dec 31 2023)
Q4
(Sep 30 2023)
Q3
(Jun 30 2023)
Q2
(Mar 31 2023)
Q1
Y / Y Revenue Change -
Seq. Revenue Change -
Revenue In Millions $0.00
Gross Profit Margin -
Gross Profit Margin Total Ranking #
Gross Profit In Millions $0.00
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting First Quarter 2024 Gross Profit Margin
Learn about Gross Margin
CERE's Gross Profit Margin first quarter 2024 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Gross Profit Margin Statistics
High Average Low
64.39 % 49.04 % 23.56 %
(Nov 30 2012)   (May 31 2015)




Other Gross Profit Margin Profitability Ratios
CERE's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
CERE's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for CERE's Competitors
Gross Profit Margin Profit Margin for Cerevel Therapeutics Holdings Inc 's Suppliers
Gross Profit Margin Profit Margin for CERE's Customers

You may also want to know
CERE's Annual Growth Rates CERE's Profitability Ratios CERE's Asset Turnover Ratio CERE's Dividend Growth
CERE's Roe CERE's Valuation Ratios CERE's Financial Strength Ratios CERE's Gross Profit Growth
CERE's Roa CERE's Inventory Turnover Ratio CERE's Growth Rates CERE's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Mar 31 2024, within Major Pharmaceutical Preparations Industry Gross Profit MarginMar 31 2024 MRQ Gross ProfitMar 31 2024 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.